SCHEMBL29601648

SCHEMBL29601648

CC(=O)C(=O)c1ccccc1OCC(F)(F)F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
HCRTR1 O43613 5/20 0.46
HCRTR2 O43614 5/20 0.46
KDM4E B2RXH2 3/20 0.45
LMNA P02545 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
PRMT5 O14744 1/20 0.44
S1PR1 P21453 1/20 0.44
MRGPRX1 Q96LB2 2/20 0.43
UGCG Q16739 1/20 0.43
NPSR1 Q6W5P4 2/20 0.42
RXFP1 Q9HBX9 1/20 0.42
MEN1 O00255 1/20 0.41
S1PR2 O95136 1/20 0.41
S1PR4 O95977 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
XBP1 P17861 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17859344 0.87 LMNA (0.60) ALDH1A1HCRTR1HCRTR2KDM4ELMNA
SCHEMBL10451670 0.83 KDM4E (0.49) ALDH1A1HCRTR1HCRTR2KDM4ELMNA
SCHEMBL1434118 0.81 ALDH1A1 (0.59) ALDH1A1KDM4ELMNASMN1; SMN2PRMT5
Acetic Acid SCHEMBL5482846 0.81 HTT (0.52) ALDH1A1HCRTR1HCRTR2KDM4ELMNA
SCHEMBL19604253 0.81 ABCB1 (0.50) ALDH1A1HCRTR1HCRTR2KDM4ECYP1A2
SCHEMBL10499645 0.81 SLC6A3 (0.54) ALDH1A1KDM4ELMNASMN1; SMN2CYP1A2
SCHEMBL19599253 0.81 UGCG (0.48) ALDH1A1HCRTR1HCRTR2KDM4ECYP1A2
SCHEMBL6789664 0.80 KDM4E (0.47) ALDH1A1HCRTR1HCRTR2KDM4ELMNA
SCHEMBL11784830 0.80 ALDH1A1 (0.57) ALDH1A1KDM4ELMNASMN1; SMN2PRMT5
SCHEMBL3441526 0.80 HTT (0.54) ALDH1A1KDM4ELMNACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4005637-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2022-06-01 EP disclosed